Failure to comply with child-resistant closure requirement prompts recall
March 11, 2015
government provided pic of recalled medicine
The U.S. government has announced a voluntary recall of approximate 898,000 units of Rugby Children's Pain & Fever Concentrated Drops due to failure to meet child-resistant closure requirement. The problem doesn't exist in the primary package itself, as the product shipped in child-resistant packaging as required by the Poison Prevention Packaging Act. Instead, the recall was prompted by what Altaire Pharmaceuticals Inc. chose to include in the product carton with the medicine--a dosage dropper.
The dosage dropper most likely was intended to prevent overdose by offering parents a convenient way to measure and deliver the medicine. The U.S. Consumer Product Safety Commission says, the dosage dropper presents a hazard, though. In the official announcement from the U.S. Consumer Product Safety Commission, Office of Information and Public Affairs, the agency stated, "When in use, a child can access the medicine, posing serious health problems or death if more than the recommended dosage is consumed."
No incidents or injuries have been reported.
The recall involves Rugby Children's Pain & Fever Concentrated Drops (Acetaminophen Drops) in a 0.5-fl. oz. bottle size with the UPC code 305361936723.The affected lot numbers are 09002, 09379, 10272, 10368, 10487, 09131, 09394, 10273, 10406, 11058, 09215, 10154, 10366 and 10433. The product was sold at drug stores, grocery stores and other retailers nationwide between January 2009 and June 2011 for about $4.
Consumers are advised store the product with its original child-resistant closure in place and contact Altaire Pharmaceuticals at 800-258-2471 for a free replacement dropper.
.
About the Author
You May Also Like